RO87010B1 - Intensified anticolinergic medicinal preparation - Google Patents
Intensified anticolinergic medicinal preparationInfo
- Publication number
- RO87010B1 RO87010B1 RO111313A RO11131383A RO87010B1 RO 87010 B1 RO87010 B1 RO 87010B1 RO 111313 A RO111313 A RO 111313A RO 11131383 A RO11131383 A RO 11131383A RO 87010 B1 RO87010 B1 RO 87010B1
- Authority
- RO
- Romania
- Prior art keywords
- anticolinergic
- intensified
- medicinal preparation
- intoxication
- irreversible
- Prior art date
Links
- HOBWAPHTEJGALG-JKCMADFCSA-N [(1r,5s)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfate Chemical compound [O-]S([O-])(=O)=O.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1 HOBWAPHTEJGALG-JKCMADFCSA-N 0.000 abstract 1
- 229960002028 atropine sulfate Drugs 0.000 abstract 1
- 239000000812 cholinergic antagonist Substances 0.000 abstract 1
- 230000001713 cholinergic effect Effects 0.000 abstract 1
- 239000000544 cholinesterase inhibitor Substances 0.000 abstract 1
- 229960002102 imipramine hydrochloride Drugs 0.000 abstract 1
- XZZXIYZZBJDEEP-UHFFFAOYSA-N imipramine hydrochloride Chemical compound [Cl-].C1CC2=CC=CC=C2N(CCC[NH+](C)C)C2=CC=CC=C21 XZZXIYZZBJDEEP-UHFFFAOYSA-N 0.000 abstract 1
- 230000035987 intoxication Effects 0.000 abstract 1
- 231100000566 intoxication Toxicity 0.000 abstract 1
- 230000002427 irreversible effect Effects 0.000 abstract 1
- 230000002093 peripheral effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
- 229960004499 scopolamine hydrobromide Drugs 0.000 abstract 1
- WTGQALLALWYDJH-MOUKNHLCSA-N scopolamine hydrobromide (anhydrous) Chemical compound Br.C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 WTGQALLALWYDJH-MOUKNHLCSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Inventia se refera la un preparat medicamentos anticolinergic potentat, care în scopul tratamentului efectelor colinergice centrale si periferice din intoxicatia cu anticolinesterazice ireversibile si reversibile, este constituit din 0,08...0,15% atropina sulfat, 0,03...0,5% scopolamina bromhidrat 2,0...2,5% imipramina clorhidrat si apa bidistilata pîna la 100 ml.The invention relates to a potent anticholinergic drug which in order to treat the central and peripheral cholinergic effects of the irreversible and reversible anticholinesterase intoxication consists of 0.08 ... 0.15% atropine sulfate, 0.03 ... 0 , 5% scopolamine hydrobromide 2.0 ... 2.5% imipramine hydrochloride and water distilled to 100 ml.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO111313A RO87010B1 (en) | 1983-06-17 | 1983-06-17 | Intensified anticolinergic medicinal preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RO111313A RO87010B1 (en) | 1983-06-17 | 1983-06-17 | Intensified anticolinergic medicinal preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RO87010A2 RO87010A2 (en) | 1985-05-20 |
| RO87010B1 true RO87010B1 (en) | 1985-05-31 |
Family
ID=20113239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RO111313A RO87010B1 (en) | 1983-06-17 | 1983-06-17 | Intensified anticolinergic medicinal preparation |
Country Status (1)
| Country | Link |
|---|---|
| RO (1) | RO87010B1 (en) |
-
1983
- 1983-06-17 RO RO111313A patent/RO87010B1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RO87010A2 (en) | 1985-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY101177A (en) | Improvements in pharmaceutically acceptable salts | |
| PT86311A (en) | Process for the preparation of tetra-hydro-pyridine-oxime o replaced of cholinergic agents and of pharmaceutical compositions containing them | |
| ZA902153B (en) | Use of 5-methyltetrahydrofolic acid,5-formyltetrahydrofolic acid and their pharmaceutically acceptable salts in the preparation of pharmaceutical compositions in controlled-release form active in the therapy of organic mental disturbances and the relative pharmaceutical compositions | |
| IL152659A (en) | Liquid pharmaceutical compositions comprising a pegylated human erythropoietin protein and a multiple charged inorganic anion, in a pharmaceutically acceptable buffer | |
| CA2129995A1 (en) | Piperidinyl thiacyclic derivatives | |
| DK201788D0 (en) | DISINFECTIVE COMPOSITIONS AND PROCEDURES FOR THEIR PREPARATION AND USE | |
| GR3032021T3 (en) | High dose formulations | |
| BE905890A (en) | MONOCLONAL ANTIBODIES WITH CROSS REACTION AND CROSS PROTECTION AGAINST P.AERUGINOSA SEROTYPES. | |
| EP0187251A3 (en) | 1,4-dihydropyridines; a process and intermediates for their preparation and their use as medicaments | |
| BR9609971A (en) | Preparation of pharmaceutical combinations containing erythropoietin and iron preparations | |
| MY119090A (en) | Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them | |
| TR199700801T1 (en) | Prevention of angiogenesis using Interleukin 12. | |
| DK0585314T3 (en) | ||
| BR9714632A (en) | Pharmaceutical combination preparation, process for the production of pharmaceutical combination preparations, use of erythropoietin and iron preparations, and pharmaceutical packaging unit | |
| IL109076A0 (en) | Imidazolo-quinoxalinones, their preparation and pharmaceutical compositions containing them | |
| IL102032A0 (en) | 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them | |
| FR2691149B1 (en) | NOVEL THIOCHROMANIC COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. | |
| MX9200607A (en) | 9-AMINO TETRA HYDRO ACRIDINES AND RELATED COMPOUNDS, A PROCEDURE FOR THEIR PREPARATION AND USE AS MEDICINES. | |
| ZA859695B (en) | 2-(arylalkyloxymethyl)morpholine,preparation thereof and their application as drugs which are useful in the treatment of disorders of the central nervous system | |
| ATE275953T1 (en) | 2,3 DIARYL-1-BENZOPYRAMES FOR THE TREATMENT OF DERMATITIS | |
| BE1003232A3 (en) | SEQUENTIAL POLYPEPTIDES HAVING IMMUNOLOGICAL ACTIVITY, PROCESS FOR THEIR PREPARATION, AND THEIR USE. | |
| JPS6438073A (en) | Novel derivative of tetrahydropyridine, manufacture and intermediate, use as drug and medicinal composition | |
| FR2360313A1 (en) | USEFUL PHARMACEUTICAL COMPOSITIONS ESPECIALLY FOR THE TREATMENT OF SEBORRHEA | |
| RO93806B1 (en) | Antiasthmatical medicinal tablets for pedriatic use | |
| BR9714184A (en) | Use of bonzoillyl-1,2,3,6-tetrahydropyridines |